These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 31502758)

  • 1. Late-onset hypogonadism: metabolic impact.
    Grossmann M; Ng Tang Fui M; Cheung AS
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset hypogonadism and lifestyle-related metabolic disorders.
    Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
    Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.
    Gianatti EJ; Grossmann M
    Diabet Med; 2020 Feb; 37(2):174-186. PubMed ID: 31006133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypogonadism and male obesity: Focus on unresolved questions.
    Grossmann M
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):11-21. PubMed ID: 29683196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone, diabetes mellitus, and the metabolic syndrome.
    Spark RF
    Curr Urol Rep; 2007 Nov; 8(6):467-71. PubMed ID: 18042326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complex association between metabolic syndrome and male hypogonadism.
    Dimopoulou C; Goulis DG; Corona G; Maggi M
    Metabolism; 2018 Sep; 86():61-68. PubMed ID: 29656047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadotropic Hypogonadism in Men With Diabesity.
    Dhindsa S; Ghanim H; Batra M; Dandona P
    Diabetes Care; 2018 Jul; 41(7):1516-1525. PubMed ID: 29934480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Testosterone and mortality].
    Stárka L
    Vnitr Lek; 2016; 62(9 Suppl 3):127-130. PubMed ID: 27734705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.
    Rao PM; Kelly DM; Jones TH
    Nat Rev Endocrinol; 2013 Aug; 9(8):479-93. PubMed ID: 23797822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
    Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
    Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the hypothalamic-pituitary-adrenal axis dysregulation on the metabolic profile of patients affected by diabetes mellitus-associated late onset hypogonadism.
    Tirabassi G; Chelli FM; Ciommi M; Lenzi A; Balercia G
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):53-9. PubMed ID: 26643209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Disorders and Male Hypogonadotropic Hypogonadism.
    Pivonello R; Menafra D; Riccio E; Garifalos F; Mazzella M; de Angelis C; Colao A
    Front Endocrinol (Lausanne); 2019; 10():345. PubMed ID: 31402895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
    Saad F
    Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and hypogonadism--two peas in a pod.
    Ebrahimi F; Christ-Crain M
    Swiss Med Wkly; 2016; 146():w14283. PubMed ID: 26999489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management.
    Grossmann M; Matsumoto AM
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1067-1075. PubMed ID: 28359097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
    Hackett G
    Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DYSREGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INCREASES CENTRAL BODY FAT ACCUMULATION IN MALES AFFECTED BY DIABETES MELLITUS AND LATE-ONSET HYPOGONADISM.
    Tirabassi G; Muscogiuri G; Colao A; Balercia G
    Endocr Pract; 2016 Apr; 22(4):427-33. PubMed ID: 26684153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
    Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
    Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone in obesity, metabolic syndrome and type 2 diabetes.
    Stanworth R; Jones T
    Front Horm Res; 2009; 37():74-90. PubMed ID: 19011290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.